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Abstract
Toluene/o-xylene monooxygenase (ToMO) is a non-heme diiron protein that activates O2 for 
subsequent arene oxidation. ToMO utilizes four protein components, a catalytic hydroxylase 
(ToMOH), a regulatory protein (To-MOD), a Rieske protein (ToMOC), and a reductase 
(ToMOF). Here, we examine O2 activation and substrate hydroxylation in the presence of all four-
protein components. Studies of this system demonstrate the importance of ToMOC for formation 
of the active hydroxylating species that are not revealed when dithionite and mediators are used as 
the reductant. This reactivity is discussed in light of other O2-activating, non-heme diiron 
enzymes.
O2 activation by non-heme diiron enzymes generates reactive intermediates capable of 
hydrocarbon hydroxylation, epoxidation, desaturation, and radical formation.1 Because 
structurally similar active sites catalyze diverse chemical transformations, the mechanisms 
by which these diiron enzymes control reactivity are of particular interest.
Toluene/o-xylene monooxygenase (ToMO) belongs to a family of diiron proteins termed 
bacterial multicomponent monooxygenases (BMMs) that activate O2 to oxidize hydrocarbon 
substrates (Scheme 1).2
ToMO catalyzes the hydroxylation of toluene to form o-, m-, and p-cresol, and can also 
perform the catalytic, regiospecific hydroxylation of phenol to form catechol.3 Four protein 
components are required to carry out efficient catalysis, a dimeric hydroxylase (ToMOH), a 
regulatory protein (ToMOD), a reductase (ToMOF), and a Rieske protein (ToMOC).2a 
Previous O2-activation studies with ToMO utilized a simplified protein system comprising 
ToMOH, ToMOD, and sodium dithionite as reductant with and methyl viologen (2e-MV) as 
an electron-transfer mediator.4 In these earlier experiments, a colorless intermediate termed 
ToMOHperoxo was generated.4a Here, we sought to determine whether single turnover by the 
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native system, ToMOred (ToMOH, ToMOD, ToMOC, ToMOF, and NADH) differs from 
that observed using 2e-MV to reduce ToMOH.
Under single turnover conditions with limiting [NADH], the rate of phenol hydroxylation to 
form catechol by ToMOred and O2 depends on the ratio of ToMOC per diiron sites of 
ToMOH, hereafter ToMOC:diiron (Figure 1).
Using 0.01ToMOC:diiron, 36(3)% of the diiron sites form catechol by 2 s with a rate 
constant of 8(1) s−1. A slow increase in product formation follows (Figure S1). After 10 
min, 84(4)% of the diiron sites produce catechol. In contrast, using 1ToMOC:diiron, 70(4)% 
of the diiron sites produce catechol by 2 s. The product yields after 10 min are similar in 
both reactions. These results suggest that two phases of product formation occur, a fast 
phase and a slow phase. Inclusion of stoichiometric ToMOC promotes product formation by 
increasing the amount of product formed in the fast phase. Importantly, the rate constant of 
each phase is not significantly affected by ToMOC concentration, demonstrating that 
ToMOC does not directly participate in substrate hydroxylation.
In these single-turnover experiments, pre-incubation of NADH and the protein components 
of ToMO pre-forms the reduced hydroxylase, and product quantification requires rapid 
protein precipitation, which releases product bound at the active site. Thus, ToMOC must 
influence steps(s) between reduction of the diiron site and product release. These steps 
would include O2 activation, aromatic substrate binding, substrate hydroxylation, and any 
conformational changes necessary for the initiation of each step.
In the presence of 0.01ToMOC:diiron, O2 activation by ToMOred yields rapid absorbance 
changes at 420 and 675 nm (Figure 2), which are not observed when 2e-MV is used as the 
reductant.4a Because ToMOC contains a redoxdependent chromophore, higher ratios of 
ToMOC:diiron were not suitable for monitoring absorbance changes caused by the diiron 
center.§ These absorbance changes are absent when either hydroxylase or O2 is omitted 
(Figure S2), strongly indicating that the features result from reaction of O2 with the 
hydroxylase.
When the concentration of O2 was varied between 375 and 625 µM, the observed kinetics 
were unchanged (Figure S3 and Table S1), indicating that the interaction of ToMOH with 
O2 must be faster than the first observable step, as found for related diiron enzymes.5 The 
simplest interpretation of these data invokes the formation of four species: 675A, tmax ≤ 2 
ms, kdecay = 40(5) s−1; 420A, tmax = 200 ms, kformation = 23(1) s−1; 420B, tmax ~ 70 s, 
kformation 0.023(2) s−1; and Hox, tmax > 1000 s, kformation 0.0018(2) s−1.
The maximum accumulation of 675A occurs before the mixing time of the instrument, 2 ms, 
which limits the ability to fully characterize this species by rapid mixing techniques. 
Intermediates 420A and 420B were characterized by rapid freeze-quench (RFQ) Mössbauer 
§Under these conditions, the maximum absorbance change for redox cycling of ToMOC and ToMOF is 3 mAU at 420 nm and 0.25 
mAU at 675 nm.
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spectroscopy.† RFQ Mössbauer reactions were conducted at 0.1ToMOC:diiron and 
1ToMOC:diiron. Both sample conditions yielded similar Mössbauer parameters (Figure S4).
Species 420A accumulates with a rate constant similar to that observed for ToMOHperoxo 
(~26 s−1), the colorless intermediate previously reported when 2e-MV was used to reduce 
ToMOH.4a For a sample frozen after 0.2 s, approximately 80% of the iron sites are iron(III) 
with Mössbauer parameters δ = 0.54 mm/s and ΔEQ = 0.67 mm/s (Figure 2). These 
Mössbauer parameters are identical to those reported for ToMOHperoxo.4a The remaining 
20% is iron(II) with Mössbauer parameters δ = 1.31 mm/s and ΔEQ = 2.88 mm/s, 
corresponding to unreacted diiron(II).4a,6 420A is stable for > 6 s. Because of its long 
lifetime, we initially questioned whether this species is a diiron-O2 intermediate. Diiron-O2 
adducts with lifetimes from 3 s to 3 h have been reported, however.7
Given the significant difference in the absorption profiles of 420A (Figure S5) and 
ToMOHperoxo, these intermediates must be different. Altering the reaction pH did not 
quench the absorbance corresponding to 420A (Figure S6), demonstrating that excess 
protons alone cannot induce formation of ToMOHperoxo rather than 420A. Thus, other 
changes must be required, such as a conformational change.
Generation of 420B and formation of Hox occurs with rate constants significantly smaller 
than steady-state turnover (toluene hydroxylation, ~0.5 s−1),9 suggesting that these steps are 
not relevant to catalysis. Analysis of intermediate 420B is provided in the Supporting 
Information. The final species has negligible absorbance at 420 and 675 nm, consistent with 
the diiron(III) resting state, Hox.
The absorbance changes were also monitored in the presence of excess toluene (Figure 3). 
The decay of the first species, 675A, is unaffected by toluene, indicating that this species is 
not responsible for oxidizing aromatic substrates. In contrast, addition of toluene 
significantly alters the absorbance changes at 420 nm.
The absorbance changes at 420 nm are well described by an A–>B–>C–> D model with rate 
constants of 40(5) s−1, 15(3) s−1, and 0.61(4) s−1. Based on the wavelength of maximum 
absorbance, rate of formation, and Mössbauer parameters, we assign the first species to 
intermediate 420A. The decay of 420A occurs rapidly in the presence of substrate (15 s−1), 
consistent with 420A being responsible for substrate oxidation. Instead of forming Hox 
directly, 420A decays to generate a species with tmax ~ 0.5 s (420-Ar), corresponding to 
toluene oxidation. Species 420-Ar is not observed in the absence of substrate and absorbs at 
both 420 and 675 nm. The formation rate constant of 420-Ar is similar to that observed for 
hydroxylation of phenol in our single-turnover experiments above. Binding of phenolic 
derivatives to the diiron active site increases the absorbance at 420 and 675 nm (Figure S7). 
Based on these observations, we assign 420-Ar to a cresol-diiron adduct resulting from 
hydroxylation of toluene.
†Only ToMOH was enriched with 57Fe. The natural abundance of 57Fe is 2%;14 therefore the spectra result exclusively from the iron 
atoms of ToMOH.
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In the final phase, 420-Ar decays with a rate constant of 0.61 s−1, and the absorbance at 420 
and 675 nm decreases. These changes are consistent with product release from the active 
site. The rate constant associated with this step is much smaller than that observed in our 
single-turnover experiments but is similar to the rate of steady-state turnover.9 Thus, release 
of product may be rate limiting for steady-state turnover, as previously proposed for the 
analogous BMM toluene 4-monooxygenase (T4MO) based on X-ray crystallographic data.10 
O2 activation in the presence of phenol was also examined, but proved to be much more 
complex than that observed with toluene (Figure S8). The increased complexity in the 
presence of phenol probably results from formation of both diiron-phenol and diiron-
catechol adducts during single turnover.
Three important conclusions are evident from this work: (i) ToMOC is critical for formation 
of an active hydroxylating species, (ii) in the presence of ToMOC a previous undetected 
intermediate, 420A, is responsible for substrate hydroxylation, (iii) ToMOH is capable of 
greater than half-sites reactivity. Our conclusions are discussed below in light of previous 
work and other diiron proteins.
The difference in reactivity between the natural system and the 2e-MV simulation is 
surprising, given that the BMM soluble methane monooxygenase (sMMO) undergoes single 
turnover very well using 2e-MV as the reduction system.11 A comparison of the absorbance 
changes observed for ToMO and sMMO are provided in Figure S9. For the multicomponent, 
non-heme diiron protein stearoyl-acyl carrier protein desaturase (Δ9D), an inactive peroxo 
species forms when the diiron reducing protein is replaced with sodium dithionite.12 The 
chemical or physical changes that contribute to promotion of activity by the ferredoxin of 
Δ9D remain unknown. For toluene monooxygenases, however, a recent X-ray structure of 
the hydroxylase and Rieske protein complex for T4MO hints at a possible mechanism for 
Rieske protein function. In the 2.05-Å structure of the complex, residue E104 adopts a 
different conformation than those previously reported for BMMs (Figure 4).13
Movement of E104 alters hydrogen bonding at the active site.13 Computational analyses of 
peroxo intermediates formed at carboxylate-bridged diiron centers indicate that the 
transition near 420 nm corresponds to LMCT from both the carboxylate and the peroxo 
ligand at the diiron site, and that these transitions are sensitive to the carboxylate 
orientation.8 Thus, the differing absorbance features between the 2e-MV reduced system and 
the Rieske protein reduced system may arise from conformational changes of E104, a 
difference in the peroxo ligand coordination, or alteration of the hydrogen-bonding network 
near the active site.
The structure of the newly discovered intermediate 420A may correspond to any one of 
many (hydro)peroxo-diiron conformations. Because 420A is long-lived and has Mössbauer 
properties similar to those observed and calculated for µ-1,2-peroxodiiron intermediates,8 
we tentatively assign 420A as such a species.
Previous O2-activation experiments reported half-sites reactivity with respect to the 
hydroxylase dimer.4a,4d The current work shows greater than 50% reactivity. This difference 
in activity may be a result of includng ToMOC or of the ratio of O2 to ToMOH used in our 
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experiments. Here, 1.25 equivalents of O2 per diiron sites are present, whereas in previous 
Mössbauer studies4a,4d we estimate that the ratio was ~ 0.6, based on the O2 saturation limit.
In summary, we demonstrate the importance of the natural reduction component for efficient 
hydroxylation and O2 activation by the multicomponent diiron protein, ToMO. Using this 
knowledge, we were able to identify a previously unobserved species, 420A, during O2 
activation by the diiron protein ToMO. A proposed scheme to account for the observed O2-
activation kinetics is given in Figure 4B. Further insight into the effects of ToMOC at a 
molecular level would benefit from high-resolution structural data of the oxidized and 
reduced systems.
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Figure 1. 
Hydroxylation of phenol to catechol at 4 °C during single turnover by ToMO. The 
concentrations of each component are as follows: 50 µM ToMOH (100 µM diiron sites), 100 
µM ToMOD, 1 µM (▲) or 100 µM (○) ToMOC, 0.05 µM ToMOF, 90 µM NADH, 
approximately 625 µM O2,‡ and 2 mM phenol.
‡O2–saturated buffer contains ~1.25 mM O2 at 5 °C. One-to-one mixing yields 625 µM O2.
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Figure 2. 
Analysis of O2 activation upon mixing of O2 with ToMOred at 5 °C. Left: Time resolved 
stopped-flow UV-visible spectroscopy of the reaction between ToMOred containing 
0.01ToMOC:diiron. The absorbance changes at 420 and 675 nm are shown in orange and 
grey, respectively. Fits to the absorbance traces are shown in black. Right: Mössbauer 
spectroscopy of the ToMOH diiron site at 0.2 s isolated by rapid freeze-quenching of a 
reaction containing 0.1ToMOC:diiron. The data were recorded at 80 °C. The Mössbauer 
signal is shown in grey and the simulated fits in light blue for the Fe3+ intermediate (δ = 
0.54 mm/s and ΔEQ = 0.67 mm/s, 80%) and in red for unreacted Fe2+ starting material (δ = 
1.31 mm/s and ΔEQ = 2.88 mm/s, 20%).
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Figure 3. 
Analysis of O2 activation upon mixing of O2 with ToMOred in the presence of toluene at 5 
°C. Left: Time resolved stopped-flow UV-visible spectroscopy and ananlysis under the 
following conditions: 1diiron—1ToMOD—0.01ToMOC—0.0005ToMOF—0.9NADH—
20toluene—6.25O2. The absorbance changes at 420 and 675 nm are shown in orange and 
grey, respectively. Fits to the absorbance traces are shown in black. Right: Analysis of 
intermediates at 0.2 s by rapid freeze-quench Mössbauer spectroscopy under the following 
conditions: 1diiron—1ToMOD—0.1ToMOC—0.0005ToMOF—0.9NADH—8toluene—
1.25O2. The Mössbauer signal is shown grey and the simulated species in light blue (δ = 
0.52 mm/s and ΔEQ = 0.67 mm/s, 52%), green (δ = 0.845 mm/s and ΔEQ = 2.01 mm/s, 
27%), and red (δ = 1.26 mm/s and ΔEQ = 2.79 mm/s, 20%).
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Figure 4. 
Influences of ToMOC on the activity of ToMOred. Based on the Rieske-hydroxylase 
complex of T4MO, we propose that an unusual E104 conformation (A) is responsible for the 
activity seen in the presence of ToMOC. A mechanistic scheme consistent with the activity 
of ToMOred is provided (B).
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Scheme 1. 
General mechanism for hydroxylation by BMMs
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